GGrantIndex
← Search

Developmental Funds

$372,407P30FY2025CANIH

Roswell Park Cancer Institute Corp, Buffalo NY

Investigators

Linked publications, trials & patents

Trial NCT07082270Trial NCT06202066Trial NCT05589844Trial NCT05338905Trial NCT05292521Trial NCT05231122Trial NCT04607291Trial NCT04533542Trial NCT04530812Trial NCT04526587Trial NCT04379518Trial NCT04358315Trial NCT04348747Trial NCT04298606Trial NCT04290962Trial NCT04269213Trial NCT04231539Trial NCT04207190Trial NCT04119830Trial NCT04110249Trial NCT04109924Trial NCT04093323Trial NCT04081389Trial NCT04073745Trial NCT04068649Trial NCT04067830Trial NCT04060446Trial NCT04032418Trial NCT04000581Trial NCT03965234Trial NCT03935347Trial NCT03899987Trial NCT03897270Trial NCT03895918Trial NCT03881735Trial NCT03880422Trial NCT03879694Trial NCT03865472Trial NCT03851081Trial NCT03793907Trial NCT03789877Trial NCT03751449Trial NCT03751436Trial NCT03736720Trial NCT03735589Trial NCT03735095Trial NCT03727789Trial NCT03727061Trial NCT03709550Trial NCT03691376Trial NCT03688945Trial NCT03685695Trial NCT03683147Trial NCT03680235Trial NCT03679585Trial NCT03679559Trial NCT03678350Trial NCT03630601Trial NCT03574792Trial NCT03457142Trial NCT03403634Trial NCT03384836Trial NCT03358719Trial NCT03348748Trial NCT03333486Trial NCT03297489Trial NCT03211416Trial NCT03206047Trial NCT03192397Trial NCT03090412Trial NCT03017131Trial NCT03011736Trial NCT02965976Trial NCT02955290Trial NCT02953457Trial NCT02947386Trial NCT02877641Trial NCT02857374Trial NCT02853318Trial NCT02833506Trial NCT02713373Trial NCT02650986Trial NCT02575885Trial NCT02575508Trial NCT02531906Trial NCT02474095Trial NCT02455557Trial NCT02452463Trial NCT02414724Trial NCT02399215Trial NCT02393755Trial NCT02334865Trial NCT02287727Trial NCT02227940Trial NCT02170389Trial NCT02166905Trial NCT02159950Trial NCT02119728Trial NCT02100254Trial NCT02072486

Abstract

Roswell Park Comprehensive Cancer Center Director, Candace Johnson (DT) is responsible for oversight and allocation of all Cancer Center Support Grant (CCSG) Developmental Funds. This budget line is critical to supporting strategically aligned pilot projects and faculty recruitment. As a stand-alone cancer center, Dr. Johnson can leverage philanthropic funds raised by the Roswell Park Alliance Foundation (RPAF) to ensure the success of CCSG Developmental Fund investments. In the current project period (2018-2023), RPAF allocated $62.6M to support high priority scientific projects. During the current project period, CCSG Developmental Funds supported 13 CCSG faculty ($1,225,000); invested in shared resources to develop new assays and techniques and to enhance new utilization of these services by CCSG members ($699,326); and 24 pilot projects were funded ($910,546). Intra- and inter- programmatic projects were initiated with the ultimate goal of team grant submissions within 2 years. The return on investment, measured by publications and grants awarded, is monitored by CCSG Administration, with reports shared with Senior Leadership bi-annually. Roswell Park faculty consistently reported excellent returns on investment. CCSG Developmental Funds and RPAF Scientific Advisory Committee (SAC) funds are administered through standardized processes wherein CCSG Administration provides back-end infrastructure using InfoReady software. Program and Senior Leaders assist in decision making by serving on the internal peer-review committees that select the most meritorious high-impact, high-risk projects for pilot project funding. Dr. Johnson ultimately manages the allocation process and ensures requests are in line with the strategic plan and cancer center priorities. The flexibility to fund innovative pilot projects is critical to CCSG faculty taking risks with their breakthrough discoveries. During the next grant period, CCSG Developmental Funds will support the following recruitment and pilot grant initiatives: • Recruitments: The Cancer Center will recruit two key investigators per year; $300,000 per year will be used to support new investigators in each of the CCSG programs over the project period. • Pilot Grants: Grants will be awarded to individual investigators through the CCSG Developmental Funds/ RPAF SAC process, with allocations to each research program, and for Team Science. Projects aligned with the strategic plan will be prioritized within the anticipated allocation of up to $300,000 per year.

View original record on NIH RePORTER →